Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert J Augustin

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|August 7, 2021
Prevention of the Onset of Age-Related Macular DegenerationEmiliano Di Carlo, Albert J Augustin
American Journal of Ophthalmology|March 28, 2006
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degenerationAlbert J Augustin, Ursula Schmidt-Erfurth
Developments in Ophthalmology|August 13, 2010
Antivascular endothelial growth factors in anterior segment diseasesStefan Scholl, Janna Kirchhof, Albert J Augustin
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Treatment of neovascular age-related macular degeneration: Current therapiesAlbert J Augustin, Stefan Scholl, Janna Kirchhof
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 23, 2012
Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment resultsManfred Tetz, Stanislao Rizzo, Albert J Augustin
Retina (Philadelphia, Pa.)|February 10, 2007
Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasoneAlbert J Augustin, Stephan Puls, Indre Offermann
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 18, 2010
Pathophysiology of macular edemaStefan Scholl, Janna Kirchhof, Albert J Augustin
Expert Opinion on Emerging Drugs|November 25, 2011
Emerging drugs for diabetic retinopathyAntonios Pipis, Stefan Scholl, Albert J Augustin
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2013
Macular pigment optical density in a Central European populationAntonios Pipis, Eftychia Touliou, Albert J Augustin
Developments in Ophthalmology|August 13, 2010
Mechanisms of ocular angiogenesis and its molecular mediatorsMartin J Siemerink, Albert J Augustin, Reinier O Schlingemann
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|August 7, 2021
Prevention of the Onset of Age-Related Macular DegenerationEmiliano Di Carlo, Albert J Augustin
American Journal of Ophthalmology|March 28, 2006
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degenerationAlbert J Augustin, Ursula Schmidt-Erfurth
Developments in Ophthalmology|August 13, 2010
Antivascular endothelial growth factors in anterior segment diseasesStefan Scholl, Janna Kirchhof, Albert J Augustin
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Treatment of neovascular age-related macular degeneration: Current therapiesAlbert J Augustin, Stefan Scholl, Janna Kirchhof
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 23, 2012
Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment resultsManfred Tetz, Stanislao Rizzo, Albert J Augustin
Retina (Philadelphia, Pa.)|February 10, 2007
Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasoneAlbert J Augustin, Stephan Puls, Indre Offermann
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 18, 2010
Pathophysiology of macular edemaStefan Scholl, Janna Kirchhof, Albert J Augustin
Expert Opinion on Emerging Drugs|November 25, 2011
Emerging drugs for diabetic retinopathyAntonios Pipis, Stefan Scholl, Albert J Augustin
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2013
Macular pigment optical density in a Central European populationAntonios Pipis, Eftychia Touliou, Albert J Augustin
Developments in Ophthalmology|August 13, 2010
Mechanisms of ocular angiogenesis and its molecular mediatorsMartin J Siemerink, Albert J Augustin, Reinier O Schlingemann
Pageof 6